MyFinsight
Home
Blog
About
Spinraza Royalties
$53,486K
(-1.57%↓ Y/Y)
Wainus Royalties
$16,436K
(57.81%↑ Y/Y)
Other Royalties
$6,036K
(16.08%↑ Y/Y)
DAWNZERASales
$26,565K
Tryngolza
$4,574K
(-76.27%↓ Y/Y)
Net income (loss)
-$114,646K
(-192.79%↓ Y/Y)
Collaborative Agreement
Revenue
$133,137K
(-60.48%↓ Y/Y)
Wainua Joint
Development Revenue
$16,189K
(30.85%↑ Y/Y)
Royalty
$75,958K
(8.59%↑ Y/Y)
Product
$31,139K
(61.57%↑ Y/Y)
Other Commercial
$11,526K
(-14.82%↓ Y/Y)
Income (loss) before
income tax benefit...
-$113,382K
(-191.78%↓ Y/Y)
Income tax benefit
(expense)
$1,264K
(6420.00%↑ Y/Y)
Investment income
$20,230K
(-18.05%↓ Y/Y)
Research And Development
Revenue
$149,326K
(-57.25%↓ Y/Y)
Commercial
$118,623K
(15.44%↑ Y/Y)
Other income, net
$987K
(867.65%↑ Y/Y)
Income (loss) from
operations
-$102,293K
(-173.16%↓ Y/Y)
Interest expense related
to sale of future...
$17,506K
(-6.12%↓ Y/Y)
Revenue
$267,949K
(-40.73%↓ Y/Y)
Gain (loss) on
investments, net
-$10,182K
(44.40%↑ Y/Y)
Interest expense
$4,618K
(12.25%↑ Y/Y)
Total operating
expenses
$370,242K
(18.58%↑ Y/Y)
Research, development and
patent
$217,107K
(-0.16%↓ Y/Y)
Selling, general and
administrative
$150,396K
(65.96%↑ Y/Y)
Cost of sales
$2,739K
(-34.02%↓ Y/Y)
Back
Back
Income Statement
IONIS PHARMACEUTICALS INC (IONS)
IONIS PHARMACEUTICALS INC (IONS)
source: myfinsight.com